TV Vision Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 5, 2025, 5:32 pm

Quick Insight

TV Vision Ltd, operating in the Entertainment & Media industry, currently faces significant challenges with a negative operating profit margin of -17.31% and a net profit of -27 Cr. The company's low Price-to-Book Value ratio of -0.12x indicates potential undervaluation by the market. However, its Interest Coverage Ratio of -18.49x raises concerns about its ability to service debt. With reserves at -149 Cr and borrowings at 7 Cr, the company must focus on improving operational efficiency and profitability to attract investor interest and strengthen its financial position. In conclusion, TV Vision Ltd's financial health requires immediate attention to sustain long-term growth and shareholder value.

Competitors of TV Vision Ltd

All Competitor Stocks of TV Vision Ltd

Quarterly Result

Last Updated: August 20, 2025, 1:55 am

Below is a detailed analysis of the quarterly data for TV Vision Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 7.57 Cr.. The value appears to be declining and may need further review. It has decreased from 9.08 Cr. (Mar 2025) to 7.57 Cr., marking a decrease of 1.51 Cr..
• For Expenses, as of Jun 2025, the value is 8.88 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 13.14 Cr. (Mar 2025) to 8.88 Cr., marking a decrease of 4.26 Cr..
• For Operating Profit, as of Jun 2025, the value is -1.31 Cr.. The value appears strong and on an upward trend. It has increased from -4.06 Cr. (Mar 2025) to -1.31 Cr., marking an increase of 2.75 Cr..
• For OPM %, as of Jun 2025, the value is -17.31%. The value appears strong and on an upward trend. It has increased from -44.71% (Mar 2025) to -17.31%, marking an increase of 27.40%.
• For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.02 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 0.02 Cr..
• For Interest, as of Jun 2025, the value is 0.17 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.13 Cr. (Mar 2025) to 0.17 Cr., marking an increase of 0.04 Cr..
• For Depreciation, as of Jun 2025, the value is 3.68 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.65 Cr. (Mar 2025) to 3.68 Cr., marking an increase of 0.03 Cr..
• For Profit before tax, as of Jun 2025, the value is -5.16 Cr.. The value appears strong and on an upward trend. It has increased from -7.82 Cr. (Mar 2025) to -5.16 Cr., marking an increase of 2.66 Cr..
• For Tax %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
• For Net Profit, as of Jun 2025, the value is -5.16 Cr.. The value appears strong and on an upward trend. It has increased from -7.83 Cr. (Mar 2025) to -5.16 Cr., marking an increase of 2.67 Cr..
• For EPS in Rs, as of Jun 2025, the value is -1.40. The value appears strong and on an upward trend. It has increased from -2.13 (Mar 2025) to -1.40, marking an increase of 0.73.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 3:38 pm

Growth

Last Updated: September 5, 2025, 1:50 pm

Balance Sheet

Last Updated: June 16, 2025, 11:10 am

Below is a detailed analysis of the balance sheet data for TV Vision Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 39.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 39.00 Cr..
• For Reserves, as of Mar 2025, the value is -149.00 Cr.. The value appears to be worsening (becoming more negative). It has deteriorated from -122.00 Cr. (Mar 2024) to -149.00 Cr., marking a decline of 27.00 Cr..
• For Borrowings, as of Mar 2025, the value is 7.00 Cr.. The value appears to be improving (decreasing). However, Reserves are negative, which is a major warning sign. It has decreased from 113.00 Cr. (Mar 2024) to 7.00 Cr., marking a decrease of 106.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 192.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 80.00 Cr. (Mar 2024) to 192.00 Cr., marking an increase of 112.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 89.00 Cr.. The value appears to be improving (decreasing). It has decreased from 110.00 Cr. (Mar 2024) to 89.00 Cr., marking a decrease of 21.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 27.00 Cr.. The value appears to be declining and may need further review. It has decreased from 42.00 Cr. (Mar 2024) to 27.00 Cr., marking a decrease of 15.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 33.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 33.00 Cr..
• For Other Assets, as of Mar 2025, the value is 29.00 Cr.. The value appears to be declining and may need further review. It has decreased from 35.00 Cr. (Mar 2024) to 29.00 Cr., marking a decrease of 6.00 Cr..
• For Total Assets, as of Mar 2025, the value is 89.00 Cr.. The value appears to be declining and may need further review. It has decreased from 110.00 Cr. (Mar 2024) to 89.00 Cr., marking a decrease of 21.00 Cr..

However, the Borrowings (7.00 Cr.) are higher than the Reserves (-149.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for TV Vision Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is -6.90. This value is below the healthy minimum of 5. It has decreased from -6.13 (Mar 24) to -6.90, marking a decrease of 0.77.
• For Diluted EPS (Rs.), as of Mar 25, the value is -6.90. This value is below the healthy minimum of 5. It has decreased from -6.13 (Mar 24) to -6.90, marking a decrease of 0.77.
• For Cash EPS (Rs.), as of Mar 25, the value is -3.08. This value is below the healthy minimum of 3. It has decreased from -1.75 (Mar 24) to -3.08, marking a decrease of 1.33.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -37.11. It has decreased from -30.18 (Mar 24) to -37.11, marking a decrease of 6.93.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -37.11. It has decreased from -30.18 (Mar 24) to -37.11, marking a decrease of 6.93.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 13.74. It has decreased from 15.06 (Mar 24) to 13.74, marking a decrease of 1.32.
• For PBDIT / Share (Rs.), as of Mar 25, the value is -2.92. This value is below the healthy minimum of 2. It has decreased from -1.49 (Mar 24) to -2.92, marking a decrease of 1.43.
• For PBIT / Share (Rs.), as of Mar 25, the value is -6.74. This value is below the healthy minimum of 0. It has decreased from -5.87 (Mar 24) to -6.74, marking a decrease of 0.87.
• For PBT / Share (Rs.), as of Mar 25, the value is -6.90. This value is below the healthy minimum of 0. It has decreased from -6.12 (Mar 24) to -6.90, marking a decrease of 0.78.
• For Net Profit / Share (Rs.), as of Mar 25, the value is -6.90. This value is below the healthy minimum of 2. It has decreased from -6.13 (Mar 24) to -6.90, marking a decrease of 0.77.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -6.90. This value is below the healthy minimum of 2. It has decreased from -6.13 (Mar 24) to -6.90, marking a decrease of 0.77.
• For PBDIT Margin (%), as of Mar 25, the value is -21.24. This value is below the healthy minimum of 10. It has decreased from -9.92 (Mar 24) to -21.24, marking a decrease of 11.32.
• For PBIT Margin (%), as of Mar 25, the value is -49.06. This value is below the healthy minimum of 10. It has decreased from -38.93 (Mar 24) to -49.06, marking a decrease of 10.13.
• For PBT Margin (%), as of Mar 25, the value is -50.21. This value is below the healthy minimum of 10. It has decreased from -40.62 (Mar 24) to -50.21, marking a decrease of 9.59.
• For Net Profit Margin (%), as of Mar 25, the value is -50.22. This value is below the healthy minimum of 5. It has decreased from -40.66 (Mar 24) to -50.22, marking a decrease of 9.56.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is -50.22. This value is below the healthy minimum of 8. It has decreased from -40.66 (Mar 24) to -50.22, marking a decrease of 9.56.
• For Return on Capital Employeed (%), as of Mar 25, the value is 18.40. This value is within the healthy range. It has decreased from 19.78 (Mar 24) to 18.40, marking a decrease of 1.38.
• For Return On Assets (%), as of Mar 25, the value is -47.65. This value is below the healthy minimum of 5. It has decreased from -30.61 (Mar 24) to -47.65, marking a decrease of 17.04.
• For Total Debt / Equity (X), as of Mar 25, the value is -0.05. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded -0.05.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.79. It has increased from 0.70 (Mar 24) to 0.79, marking an increase of 0.09.
• For Current Ratio (X), as of Mar 25, the value is 0.10. This value is below the healthy minimum of 1.5. It has decreased from 0.14 (Mar 24) to 0.10, marking a decrease of 0.04.
• For Quick Ratio (X), as of Mar 25, the value is 0.10. This value is below the healthy minimum of 1. It has decreased from 0.14 (Mar 24) to 0.10, marking a decrease of 0.04.
• For Interest Coverage Ratio (X), as of Mar 25, the value is -18.49. This value is below the healthy minimum of 3. It has decreased from -5.87 (Mar 24) to -18.49, marking a decrease of 12.62.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -42.73. This value is below the healthy minimum of 3. It has decreased from -23.05 (Mar 24) to -42.73, marking a decrease of 19.68.
• For Enterprise Value (Cr.), as of Mar 25, the value is 23.69. It has decreased from 24.68 (Mar 24) to 23.69, marking a decrease of 0.99.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.44. This value is below the healthy minimum of 1. It has increased from 0.42 (Mar 24) to 0.44, marking an increase of 0.02.
• For EV / EBITDA (X), as of Mar 25, the value is -2.09. This value is below the healthy minimum of 5. It has increased from -4.26 (Mar 24) to -2.09, marking an increase of 2.17.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.32. This value is below the healthy minimum of 1. It has decreased from 0.33 (Mar 24) to 0.32, marking a decrease of 0.01.
• For Price / BV (X), as of Mar 25, the value is -0.12. This value is below the healthy minimum of 1. It has increased from -0.16 (Mar 24) to -0.12, marking an increase of 0.04.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.32. This value is below the healthy minimum of 1. It has decreased from 0.33 (Mar 24) to 0.32, marking a decrease of 0.01.
• For EarningsYield, as of Mar 25, the value is -1.52. This value is below the healthy minimum of 5. It has decreased from -1.21 (Mar 24) to -1.52, marking a decrease of 0.31.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness